This federal contract award, valued at $1,076.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of OMIDRIA 1-0.3% vial, a medical product used in ophthalmic procedures. The contract has an ultimate completion date of January 24, 2025 and uses a firm fixed-price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating open competition. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/3/25, 11:20 AM